Kyrgyzstan vs Suriname: Cause of death, by non-communicable diseases, ages 5-14, male
Kyrgyzstan
34.7%
in 2021
Suriname
34.9%
in 2021
Kyrgyzstan rank
99th
Suriname rank
96th
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Kyrgyzstan
- Suriname
How they compare
Suriname currently reports 34.9% against 34.7% in Kyrgyzstan, a difference of 0.2%.
Across all 6 years both countries report, Suriname has been ahead every year.
Kyrgyzstan ranks 99th and Suriname ranks 96th of 185 countries.
Suriname has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kyrgyzstan | Suriname | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 27.0% | 29.7% | 2.7% | Suriname |
| 2010s | 34.5% | 36.8% | 2.2% | Suriname |
| 2020s | 34.7% | 37.6% | 2.9% | Suriname |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Kyrgyzstan or Suriname?
- Suriname, at 34.9% against 34.7% in Kyrgyzstan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Kyrgyzstan and Suriname?
- 0.2%, with Suriname ahead.
- How many years of comparable data are there for Kyrgyzstan and Suriname?
- 6 years are reported by both, from 2000 to 2021.
- How do Kyrgyzstan and Suriname rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Kyrgyzstan ranks 99th and Suriname ranks 96th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.